Odontoprev SA
BOVESPA:ODPV3

Watchlist Manager
Odontoprev SA Logo
Odontoprev SA
BOVESPA:ODPV3
Watchlist
Price: 13.87 BRL 1.17% Market Closed
Market Cap: R$7.7B

Relative Value

The Relative Value of one ODPV3 stock under the Base Case scenario is 10.64 BRL. Compared to the current market price of 13.87 BRL, Odontoprev SA is Overvalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ODPV3 Relative Value
Base Case
10.64 BRL
Overvaluation 23%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

ODPV3 Competitors Multiples
Odontoprev SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Odontoprev SA
BOVESPA:ODPV3
7.6B BRL 3.1 13 8.7 9.5
US
UnitedHealth Group Inc
NYSE:UNH
255.8B USD 0.6 21.2 0 0
US
Anthem Inc
LSE:0HG8
74.6B USD 0.4 13 0 0
US
Elevance Health Inc
NYSE:ELV
62.4B USD 0.3 11 0 0
US
Humana Inc
NYSE:HUM
20.9B USD 0.2 17.6 0 0
US
Centene Corp
NYSE:CNC
17.9B USD 0.1 -2.7 0 0
US
Molina Healthcare Inc
NYSE:MOH
7.2B USD 0.2 15.3 3 3.7
US
Healthequity Inc
NASDAQ:HQY
6.7B USD 5.2 35 16.3 24.7
US
Magellan Health Inc
F:MAH1
2.2B EUR 0.5 8.5 12.9 38.5
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 1.1 25 12.1 12.7
US
Clover Health Investments Corp
NASDAQ:CLOV
1B USD 0.6 -17.4 -14.5 -14.1
P/E Multiple
Earnings Growth PEG
BR
Odontoprev SA
BOVESPA:ODPV3
Average P/E: 17.7
13
4%
3.2
US
UnitedHealth Group Inc
NYSE:UNH
21.2
21%
1
US
A
Anthem Inc
LSE:0HG8
13
11%
1.2
US
Elevance Health Inc
NYSE:ELV
11
11%
1
US
Humana Inc
NYSE:HUM
17.6
37%
0.5
US
Centene Corp
NYSE:CNC
Negative Multiple: -2.7 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
15.3
19%
0.8
US
Healthequity Inc
NASDAQ:HQY
35
69%
0.5
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
25
35%
0.7
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -17.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
BR
Odontoprev SA
BOVESPA:ODPV3
Average EV/EBITDA: 10.6
8.7
4%
2.2
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
3
10%
0.3
US
Healthequity Inc
NASDAQ:HQY
16.3
25%
0.7
US
M
Magellan Health Inc
F:MAH1
12.9
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
12.1
44%
0.3
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -14.5 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
BR
Odontoprev SA
BOVESPA:ODPV3
Average EV/EBIT: 17.8
9.5
5%
1.9
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
3.7
14%
0.3
US
Healthequity Inc
NASDAQ:HQY
24.7
37%
0.7
US
M
Magellan Health Inc
F:MAH1
38.5
N/A N/A
US
Progyny Inc
NASDAQ:PGNY
12.7
48%
0.3
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -14.1 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett